Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease—a randomised controlled trial
Nupoor Acharya, Shefali Sharma, Debashish Mishra, Sahajal Dhooria, Varun Dhir, Sanjay Jain
Topics & Concepts
MedicinePirfenidoneVital capacityInternal medicineInterstitial lung diseasePlaceboRashAdverse effectGastroenterologySurgeryLungIdiopathic pulmonary fibrosisDiffusing capacityPathologyLung functionAlternative medicineInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related DiseasesEosinophilic Disorders and Syndromes